1. A novel in situ permeation system and its utility in cancer tissue ablation.
   Masami Watanabe, 2015, Int J Oncol CrossRef
2. Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway
   Dengdian Wang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
3. CD133 and CD44 as cancer stem cell markers in bladder carcinoma
   Rania ES. Wasfy et al, 2017, Egyptian Journal of Pathology CrossRef
4. Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.
   Dong Fang et al, 2018, Int J Urol CrossRef
5. Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives
   Tomokazu Ohishi et al, 2015, IJMS CrossRef
6. Unraveling the Journey of Cancer Stem Cells from Origin to Metastasis
   Rama Krishna Nimmakayala et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
7. SIU–ICUD consultation on bladder cancer: basic science
   David J. McConkey et al, 2018, World J Urol CrossRef
8. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells
   Sangeetha Krishnamurthy et al, 2015, Nanomedicine CrossRef
9. Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.
   Shirin Sedaghat et al, 2017, Appl Immunohistochem Mol Morphol CrossRef
10. Palmitic acid is a toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1β
    Dequina A. Nicholas et al, 2017, PLoS ONE CrossRef
11. Planarians as models of cadmium-induced neoplasia provide measurable benchmarks for mechanistic studies
    Evelyn B. Voura et al, 2017, Ecotoxicology and Environmental Safety CrossRef
12. Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions
    Jaromir Hacek et al, 2020, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub CrossRef
13. Targeted Delivery of Therapeutics to Urological Cancer Stem Cells
    Qiang Liu et al, 2020, CPD CrossRef
14. Cancer Stem Cell Markers for Urinary Carcinoma
    Pu Xia et al, 2022, Stem Cells International CrossRef
15. The number of cancer stem cells in the tumor tissue and perifocal tissue of non-muscle invasive bladder cancer
    L. I. Belyakova et al, 2022, jour CrossRef
16. Impact of SOX2 function and regulation on therapy resistance in bladder cancer
    Guodong Chen et al, 2022, Front. Oncol. CrossRef
17. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy
    Zongyi Wei et al, 2022, Pharmaceutics CrossRef
18. Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
    Divya Ajmeera et al, 2023, Genes & Diseases CrossRef
19. Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance
    Tahsin Nairuz et al, 2023, Stem Cell Rev and Rep CrossRef
20. Tissue-specific cancer stem/progenitor cells: Therapeutic implications.
    Amani Yehya et al, 2023, World J Stem Cells CrossRef
21. Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer cells by interacting with nucleotide-binding oligomerization domain containing 1
    Junlong Zhuang et al, 2024, Cell Biosci CrossRef
22. Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer
    Yaobang Wang et al, 2024, J Transl Med CrossRef